Modeling and Simulating Dynamics of Complete- and Poor-Response Chronic Hepatitis B Chinese Patients for Adefovir and Traditional Chinese Medicine Plus Adefovir Therapy

Table 1

Virologic and biochemical responses at week 48.

Group	HBeAg loss	DNA <10^3	ALT < 1 ULN
EXG1 N (%)	47/207 (22.71%)	62/207 (29.95%)	118/207 (57%)
CTG1 N (%)	26/206 (12.62%)	55/205 (26.83%)	121/206 (58.74)
𝑃 value	0.0106	0.5529	0.7972
EXG2 N (%)	15/39 (38.46%)	21/39 (53.85%)	28/39 (71.70%)
CTG2 N (%)	11/35(31.43%)	20/35 (57.14%)	24/35 (68.57%)
𝑃 value	0.6974	0.9596	0.9616
EXG3 N (%)	21/34 (61.76%)	17/34 (50.00%)	24/34 (70.59%)
CTG3 N (%)	13/39 (33.33%)	23/39 (58.97%)	29/39 (74.36%)
𝑃 value	0.0282	0.5942	0.9225